Could a spinal implant tame Hard-to-Control asthma?
NCT ID NCT07709754
First seen Jul 17, 2026 · Last updated Jul 17, 2026
Summary
This study tests whether a device that stimulates the spinal cord — called pulmonary neuromodulation — can improve asthma control in adults with moderate to severe asthma that remains uncontrolled despite high-dose inhalers or biologic medications. Participants receive the implanted device and are randomly assigned to have it activated immediately or after a delay. The main goal is to see if more people achieve a meaningful improvement in their Asthma Control Test score.
What this could mean
Our plain-language read of the trial. This is informational only — not medical advice or a prediction.
- Active substance
- a spinal cord stimulation device (pulmonary neuromodulation)
- What this could lead to
- If effective, this device could offer a new option for people whose asthma remains poorly controlled despite standard medications.
- What could go wrong
- This is a small early feasibility study with only 30 participants, so results may not apply widely. The device requires surgical implantation, which carries risks such as infection or device-related complications.
This is an AI summary of the original study and may miss details. Read our disclaimer.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for MODERATE-TO-SEVERE ASTHMA are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Study contacts
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
Locations
-
National Jewish Health
Denver, Colorado, 80206, United States
Contact
-
University of Florida
Gainesville, Florida, 32611, United States
More trials for these conditions
Other studies related to the condition(s) this trial covers.
- New asthma drug shows promise in early safety trial
- New asthma shot aims to help patients breathe easier
- New asthma drug aims to cut severe attacks in half
- New program helps doctors prescribe better asthma treatment
- New asthma injection shows promise in early trial
- New asthma pill shows promise in Mid-Stage trial